Cink; Russell D.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cink; Russell D..The latest application filed is for "enzymatic processes for the preparation of (.+-.)-2-(difluoromethyl)-1-(alkoxycarbonyl)-cyclopropanecarboxylic acid and (.+-.)-2-(vinyl)-1-(alkoxycarbonyl)-cyclopropanecarboxylic acid".

Company Profile

4.14.13

Cink; Russell D. - Grayslake IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Enzymatic Processes For The Preparation Of (.+-.)-2-(difluoromethyl)-1-(alkoxycarbonyl)-cyclopropanecarboxylic Acid And (.+-.)-2-(vinyl)-1-(alkoxycarbonyl)-cyclopropanecarboxylic Acid App 20210087592 - Abrahamson; Michael J. ; et al.	2021-03-25
Enzymatic processes for the preparation of (.+-.)-2-(difluoromethyl)-1-(alkoxycarbonyl)-cyclopropanecarboxylic acid and (.+-.)-2-(vinyl)-1-(alkoxycarbonyl)-cyclopropanecarboxylic acid Grant 10,689,675 - Abrahamson , et al.	2020-06-23
Synthetic Route To Anti-viral Agents App 20200095230 - Cink; Russell D. ; et al.	2020-03-26
Synthetic route to anti-viral agents Grant 10,442,792 - Cink , et al. Oc	2019-10-15
Synthetic Route To Anti-viral Agents App 20190084966 - Cink; Russell D. ; et al.	2019-03-21
Synthetic route to anti-viral agents Grant 10,077,256 - Cink , et al. September 18, 2	2018-09-18
Enzymatic Processes For The Preparation Of (.+-.)-2-(difluoromethyl)-1-(alkoxycarbonyl)-cyclopropanecarboxylic Acid And (.+-.)-2-(vinyl)-1-(alkoxycarbonyl)-cyclopropanecarboxylic Acid App 20180258451 - Abrahamson; Michael J. ; et al.	2018-09-13
Synthetic Route To Anti-viral Agents App 20180057482 - Cink; Russell D. ; et al.	2018-03-01
Synthetic route to anti-viral agents Grant 9,809,576 - Cink , et al. November 7, 2	2017-11-07
Macrocyclic hepatitis C serine protease inhibitors Grant 9,493,506 - Chen , et al. November 15, 2	2016-11-15
Macrocyclic Hepatitis C Serine Protease Inhibitors App 20140287992 - Chen; Hui-Ju ; et al.	2014-09-25
Macrocyclic hepatitis C serine protease inhibitors Grant 8,748,374 - Chen , et al. June 10, 2	2014-06-10
Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor Grant 8,487,116 - Gomtsyan , et al. July 16, 2	2013-07-16
Fused Compounds That Inhibit Vanilloid Receptor Subtype 1 (vr1) Receptor App 20120190845 - Gomtsyan; Arthur R. ; et al.	2012-07-26
Macrocyclic Hepatitis C Serine Protease Inhibitors App 20120101031 - Chen; Hui-Ju ; et al.	2012-04-26
Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor Grant 8,071,762 - Gomtsyan , et al. December 6, 2	2011-12-06
Salts Of Fenofibric Acid And Pharmaceutical Formulations Thereof App 20090263477 - Cink; Russell D. ; et al.	2009-10-22
Anti-infective agents Grant 7,538,105 - Hutchinson , et al. May 26, 2	2009-05-26
Fused Compounds That Inhibit Vanilloid Receptor Subtype 1 (vr1) Receptor App 20080287676 - Gomtsyan; Arthur R. ; et al.	2008-11-20
Anti-Infective Agents App 20080193413 - Hutchinson; Douglas K. ; et al.	2008-08-14
Anti-infective agents Grant 7,378,414 - Hutchinson , et al. May 27, 2	2008-05-27
Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor Grant 7,375,126 - Gomtsyan , et al. May 20, 2	2008-05-20
Anti-infective agents App 20050107364 - Hutchinson, Douglas K. ; et al.	2005-05-19
Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor App 20050043351 - Gomtsyan, Arthur R. ; et al.	2005-02-24
Process for preparing 6-o-substituted erythromycin derivatives Grant 6,437,106 - Stoner , et al. August 20, 2	2002-08-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.